Group One Trading
ANVS icon

Group One Trading’s Annovis Bio ANVS Stock Holding History

Group One Trading’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Buy
69,663
+537
+0.8% +$1.47K ﹤0.01% 4333
2025
Q4 		$239K Buy
69,126
+34,499
+100% +$104K ﹤0.01% 4218
2025
Q3 		$71.7K Buy
34,627
+2,958
+9% +$7.39K ﹤0.01% 5646
2025
Q2 		$68.7K Sell
31,669
-18,910
-37% -$37.3K ﹤0.01% 5293
2025
Q1 		$75.9K Buy
50,579
+24,373
+93% +$74.6K ﹤0.01% 4829
2024
Q4 		$132K Sell
26,206
-26,561
-50% -$192K ﹤0.01% 4285
2024
Q3 		$425K Buy
+52,767
New +$494K ﹤0.01% 2982

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Group One Trading's ANVS Position: Q1 2026 in Review

Group One Trading increased its Annovis Bio (ANVS) stake by 0.78% in Q1 2026, buying an estimated $1.47K and bringing the position to 69,663 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

Group One Trading first reported a position in ANVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $425K in Q3 2024. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Group One Trading held 69,663 shares of Annovis Bio worth $155K as of Q1 2026.
  • Group One Trading bought 537 Annovis Bio shares in Q1 2026, an estimated $1.47K.
  • Annovis Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4333 holding.
  • Group One Trading first reported a position in Annovis Bio in Q3 2024 and has held it in 7 quarters since.
  • Group One Trading's Annovis Bio position peaked at $425K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.